Related Experiment Video
Updated: May 11, 2026

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Gorham stout disease in pregnancy
Janine V Calayo1, Agustin B Corro1, Patricia Ann A Factor1
1Department of Obstetrics and Gynecology, University of the Philippines-Philippine General Hospital, Ermita, Manila, Philippines.
Gorham-Stout disease (GSD) is a rare bone disorder. This case highlights GSD management during pregnancy, emphasizing the need for comprehensive care in affected women.
Area of Science:
- Rare bone diseases
- Vascular anomalies
- Skeletal disorders
Background:
- Gorham-Stout disease (GSD) is a rare, idiopathic disorder characterized by progressive bone resorption and vascular proliferation.
- Clinical manifestations of GSD are highly variable, ranging from asymptomatic cases to life-threatening systemic complications.
- Etiology and risk factors for GSD remain poorly understood, with no established correlations to age, gender, race, or environmental/infectious agents.
Observation:
- A 32-year-old pregnant woman with a history of Gorham-Stout disease presented with recurrent gingival mass.
- The mass was diagnosed as pyogenic granuloma and treated with 20 cycles of radiotherapy without disease progression.
- The patient underwent an elective cesarean section at 37 weeks for a low-lying placenta and recovered well postpartum.
Findings:
- This case represents limited documentation of Gorham-Stout disease management during pregnancy.
- The successful management of GSD symptoms and pregnancy highlights potential therapeutic approaches.
- Radiotherapy demonstrated efficacy in managing the pyogenic granuloma associated with GSD.
Implications:
- Limited data on GSD in pregnancy necessitates further research for optimal diagnosis and management strategies.
- Comprehensive prenatal, antenatal, and postnatal care protocols are crucial for pregnant women with GSD.
- Understanding GSD's variable presentation is key to improving patient outcomes and guiding future clinical practice.
More Related Videos
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Teratogenicity
Rh Blood Group
Diabetes Mellitus: Type 2 and Gestational
Upper GI Series: Barium Swallow
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
Mitral Valve Prolapse III: Nursing Management

